On April 7, 2000, this letter was first posted to The Internet resource, cancercure@egroups.com.

Hello everyone, 

Since 1979, as far as Cancer is concerned, things have not changed much. In 1979 The Book of Lists #2 reported: "10 Best Censored Stories of Recent Years      Project Censored is a nationwide research project begun at Sonoma State University in California in 1976. Significant news stories that have been ignored by the mass media are located, evaluated, and submitted to a panel of prominent judges, who rank them annually. The Sonoma State researchers stress that the suppssion of these stories is not so much the result  of a 'conspiracy' as the media's lack of perception, its drive for profits, its common interest with big business, and a general desire not to rock the boat.      Although cancer research has become a billion-dollar industry, results have been minimal. Since psident Richard Nixon signed the National Cancer Act in 1971, over $4 billion has been spent. Yet the U.S. still has the highest cancer rate in the world - 50% above the world average - and the chance for an American to survive cancer has increased only 1% since the late 1940s." Thanks to Michelle Webster's recent posting - April 4, 'Financially Bloated American Cancer Society Fails to pvent Cancer', we are afforded an update of the Sonoma State research (Cancer has fallen to #3. It is now pceeded by '#1 Multinational Corporations Profit from International Brutality' and '#2 Pharmaceutical Companies Put Profits Before Need'.):
'#3 Financially Bloated American Cancer Society Fails to pvent Cancer, Source: International Journal of Health Services, Volume 29, #3, 1999'
"The American Cancer Society (ACS) is growing increasingly wealthy, thanks to donations from the public and funding from surgeons, drug companies, and corporations that profit from cancer cures. More than half the funds raised by the ACS go for overhead, salaries, and fringe benefits for its executives and other employees, while most direct community services are handled by unpaid volunteers. The value of cash reserves and real estate totals over $1 billion, yet only 16 percent of funds go into direct services for cancer victims.
Conflicts of interest affect ACS's approach to cancer pvention . With a philosophy that emphasizes faulty lifestyles rather than environmental hazards, the ACS has refused to provide scientific testimony needed for the regulation of occupational and environmental carcinogens. The Board of Trustees includes corporate executives from pharmaceutical industries with a vested interest in the manufacture of both environmental carcinogens and anti-cancer drugs.
For More information contact author: Samuel Epstein, School of Public Health, University of Illinois, Chicago Medical Center, 2121 W. Taylor, Chicago, IL 60612-7260, Tel: (312) 996-2297, Fax: (312) 996-1374, Email: epstein@uic.edu"
Returning to 1979 - Unfortunately the editors of The Book of Lists #2 were not aware of the research of Antonio Brugarolas and Mario Gosalvez.
In 1979 in Spain these physicians witnessed these results after they had administered Thiazolidine-4-carboxylic acid ('Thioproline') to 32 human beings during a medical clinical trial:
"     Thioproline.....had a considerable antitumour effect in epidermoid carcinoma of the head and neck. Definite signs of activity were observed in epidermoid carcinoma of other regions and in other solid tumours, such as breast, renal, ovary, thyroid, and parotid cancer."
".....Histological studies showed involution and transformation into low-grade malignancies and disappearance of evidence of cancer."
'The Lancet', one of the world's pmier medical journals, reported the aforementioned sentences (January 12, 1980, pages 68 to 70).
This acid was the only chemical utilized during the course of the Brugarolas/Gosalvez clinical trial; no other substances were administered.
This acid has a degree of toxicity, as do all chemotherapeutic agents.
Vitamin C affords phenomenal protection against the toxicity of this acid; my research has demonstrated this fact.
This unique phenomenon of nature could enable physicians to administer 'mega-doses' of the acid to cancer patients.
Since November, 1997, I have been imploring medical authorities to conduct a clinical trial to determine whether cancer patients would derive considerable benefit from swallowing 'mega-doses' of vitamin C and Thiazolidine-4-carboxylic acid ('Thioproline') and 'above average' amounts of magnesium/zinc/manganese.
Thus far I have not received a definitive response from any medical authority in the United States. However, I shall continue in my quest.
Yours truly, John S. Roberts, P.O. Box H, Hobart, IN 46342  (219) 763-1933
www.jsr1936.com    The Cure for Cancer?    John Stacy Roberts    jsr1936@jsr1936.com